誉凯健康，来自福建福州，更新招股书｜美国IPO市场.20230213

Ryanben Capital 港澳IPO上市 2024-02-17

2023年2月13日，来自福建福州鼓楼区的福建誉凯健康科技有限公司的实质控股公司YUKAI Health Group Limited（以下简称“誉凯健康”）在美国证监会(SEC)提交更新后的招股书，拟于美国纳斯达克上市，股票代码 YKAI。其于2022年7月1日在SEC公开披露招股书。

誉凯健康，拟以每股4至6美元发行400万股普通股，募资或达2400万美元。

誉凯健康招股书链接：

https://www.sec.gov/Archives/edgar/data/1926299/000110465923019461/tm2219463d7_f1a.htm

主要业务

誉凯健康，致力于为中国医疗保健行业提供解决方案，主要为医院提供医疗器械整治和维修服务。

誉凯健康，有20个服务中心为公司的医院客户提供24/7全天候服务。公司在福建省的强大联系，使公司能够接触到福建省整个医疗保健系统的客户，公司在高峰期和紧急情况下快速维修设备的能力使公司成为福建省许多县、市和省级医院的首选服务提供商。

截至2022年6月30日，誉凯健康雇佣逾66名专业维修技术人员和工程师(约56名是在客户医院设施内现场工作的现场技术人员、约10名技术人员在公司总部工作，可根据需要派往不同医院)、约24名管理人员(包括投标经理、客户经理)。

股东架构

招股书显示，誉凯健康在上市前的股东架构中，主要股东包括：

郑振誉 Zhenyu Zheng，通过ZhenYu Investment Holdings Limited，持股53.0%；

张武元 Wuyuan Zhang，通过ZWY Investment Ltd，持股6.5%；

陈骥 Ji Chen，通过ChenJi Investment Group Limited，持股6.5%；

陈明新 Mingxin Chen，通过CMX Investment Group Limited，持股6.5%；

程章涛 Zhangtao Cheng，通过ZTCHEN Investment Limited，持股6.5%；

刘本征 Benzheng Liu，通过Super Wise International Holdings Limited，持股6.5%；

宋秋冉 Qiuran Song，通过QiuRan Medical Investment Co., Ltd，持股5.5%%；

易称香 Chenxiang Yi，通过CXYI Medical Investment Co., Ltd，持股5.0%。

公司架构

招股书显示，誉凯健康的公司架构如下：

管理层

招股书显示，誉凯健康的管理层如下：

郑振誉 Zhenyu Zheng, has served as our director since inception, our chairman of the board of directors and Chief Executive Officer since May 30, 2022 and the general manager of Fuzhou Yukai since September 2005. Relying on his medical background, Mr. Zheng has extensive experience in the medical equipment industry. Mr. Zheng founded Fuzhou Yukai in 2005. Under Mr. Zheng’s leadership, Fuzhou Yukai has grown to be a leading provider of medical equipment outsourcing in Fujian province. Mr. Zheng started his career working as a doctor from July 1999 to April 2000 at Fujian Medical University Affiliated Union Hospital. From May 2000 to May 2002, Mr. Zheng worked for Fujian Minwei Medical Equipment Company. Mr. Zheng also has served as the executive vice president of Fujian Medical Equipment Chamber of Commerce since October 2020 and was a vice president from October 2014 to September 2020. Mr. Zheng received his Bachelor’s degree in medicine from Fujian Medical University in July 1999.

Liping Ni, has served as our director and Chief Financial Officer since May 30, 2022, and the chief financial officer of Fuzhou Yukai since December 2010. Ms. Ni has extensive experience of more than twenty years in financial accounting, financial reporting and audit. Since December 2010, Ms. Ni has served as the chief financial officer of Fuzhou Yukai. From July 2008 to December 2010, Ms. Ni served as the financial manager of Fuzhou Wangbo Telecommunications Co., Ltd. From July 2001 to July 2008, Ms. Ni served as a financial manager of Fuzhou Huifeng Lighting Co., Ltd. Ms. Ni received her vocational degree in financial accounting and audit from Wuyi College (previous name: Nanping Teacher’s College) in June 2001.

Shenghao Zeng, will serve as our director upon effectiveness of our registration statement on Form F-1, of which this prospectus is a part. Mr. Zeng has extensive experience of more than twenty years in the legal area. Mr. Zeng has worked at Fujian Minrong Law Firm since April 2006 and has served as a director at FMM Brothers Pty. Ltd., an Australian company, since June 2022. From November 1998 to May 2003, Mr. Zeng worked at Fujian Minrong Law Firm. Mr. Zeng received his Bachelor’s degree in Economics from Xiamen University in 1991. Mr. Zeng passed the Chinese Bar exam in 1998 and has been a lawyer in the PRC since 1999. From 1999 to 2000, Mr. Zeng studied law at Huaqiao University. In 2005, Mr. Zeng received his MBA degree in accounting from the University of Technology Sydney in Australia.

George Xu, will serve as our director upon the effectiveness of our registration statement on Form F-1, of which this prospectus is a part. Mr. Xu has over 25 year of experience in the accounting and financial industry in the U.S. Mr. Xu started his public accounting practice in 1994 and has served as the principal officer of George Xu, C.P.A., P.C. since 2016. Mr. Xu leads a team of ten professionals providing services in taxation, accounting, auditing, financial planning, and business consulting for various U.S. and international individuals and companies. Mr. Xu earned a Bachelor's degree in 1986 from Shanghai University of Engineering Science and a Master's degree in taxation from the State University of New York at Albany in 1992. Mr. Xu is a board-certified public accountant licensed in the State of New York.

Yuan Yuan, will serve as our director upon effectiveness of our registration statement on Form F-1, of which this prospectus is a part. From August 2002 to October 2007, Ms. Yuan served as a staff accountant of Department of Interior Bureau of Land Management of the federal government. From September 2001 to July 2002, Ms. Yuan served as an auditor of PricewaterhouseCoopers. From June 2000 to May 2001, Ms. Yuan served as a staff finance accountant of Quest Company. Ms. Yuan received her Bachelor’s degree in accounting and finance from the University of Colorado Denver in May 2001.

公司业绩

招股书显示，在过去的2020年、2021年和2022年前六个月，誉凯健康的收入分别为 809.43万、965.03万美元和531.66万美元，相应的净利润分别为 0.77万、93.58万和91.92美元。

中介机构

誉凯健康是次IPO的的中介团队主要有：万通证券为其承销商； TPS Thayer, LLC为其审计师；锦天城(福州)、翰博文别为其公司中国律师、公司美国律师；竞天公诚、Sullivan & Worcester LLP分别为其承销商中国律师、承销商美国律师。

更多香港IPO上市资讯：www.ryanbencapital.com